«Once we have validated our findings in other populations, we will be looking to develop a cost -
effective gene profiling test that will be available for clinicians to use.
Not exact matches
The Prosigna Assay requires minimal hands - on time and runs on NanoString's proprietary nCounter ® Dx Analysis System, which offers a reproducible and cost -
effective way to
profile many
genes simultaneously with high sensitivity and precision.
Using
gene expression
profile (GEP) tests like Oncotype DX to inform treatment decision - making for breast cancer is likely to be less cost -
effective in community oncology practice than previous estimates had suggested, according to an economic simulation analysis published in the Journal of Clinical Oncology.